WO2001064834A8 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
WO2001064834A8
WO2001064834A8 PCT/US2001/004926 US0104926W WO0164834A8 WO 2001064834 A8 WO2001064834 A8 WO 2001064834A8 US 0104926 W US0104926 W US 0104926W WO 0164834 A8 WO0164834 A8 WO 0164834A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
new
novel
Prior art date
Application number
PCT/US2001/004926
Other languages
French (fr)
Other versions
WO2001064834A2 (en
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Jian-Rui Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Chongjun Xu
Radoje Drmanac
Original Assignee
Hyseq Inc
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Wang Jian Rui
Yunqing Ma
Dunrui Wang
Chen Rui Hong
Chongjun Xu
Radoje Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Y Tom Tang, Chenghua Liu, Ping Zhou, Vinod Asundi, Jie Zhang, Qing A Zhao, Feiyan Ren, Aidong J Xue, Yonghong Yang, Tom Wehrman, Wang Jian Rui, Yunqing Ma, Dunrui Wang, Chen Rui Hong, Chongjun Xu, Radoje Drmanac filed Critical Hyseq Inc
Priority to AU2001241511A priority Critical patent/AU2001241511A1/en
Priority to EP01912764A priority patent/EP1276751A4/en
Priority to US10/220,335 priority patent/US20050175607A1/en
Priority to CA002401505A priority patent/CA2401505A1/en
Publication of WO2001064834A2 publication Critical patent/WO2001064834A2/en
Publication of WO2001064834A8 publication Critical patent/WO2001064834A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne de nouveaux acides nucléiques, de nouvelles séquences polypeptidiques codées par lesdits acides nucléiques et leurs utilisations.The present invention relates to new nucleic acids, new polypeptide sequences encoded by said nucleic acids and their uses.

PCT/US2001/004926 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides WO2001064834A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001241511A AU2001241511A1 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides
EP01912764A EP1276751A4 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides
US10/220,335 US20050175607A1 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides
CA002401505A CA2401505A1 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US51512600A 2000-02-28 2000-02-28
US09/515,126 2000-02-28
US57740900A 2000-05-18 2000-05-18
US09/577,409 2000-05-18
US59770700A 2000-06-17 2000-06-17
US09/597,707 2000-06-17
US61680700A 2000-07-14 2000-07-14
US09/616,807 2000-07-14
US66464100A 2000-09-19 2000-09-19
US09/664,641 2000-09-19

Publications (2)

Publication Number Publication Date
WO2001064834A2 WO2001064834A2 (en) 2001-09-07
WO2001064834A8 true WO2001064834A8 (en) 2002-02-14

Family

ID=27541818

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/004926 WO2001064834A2 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides

Country Status (4)

Country Link
EP (1) EP1276751A4 (en)
AU (1) AU2001241511A1 (en)
CA (1) CA2401505A1 (en)
WO (1) WO2001064834A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
MXPA01013425A (en) * 1999-06-29 2003-09-04 Autogen Res Pty Ltd Novel genes and their use in the modulation of obesity, diabetes and energy imbalance.
ES2269353T3 (en) * 2000-02-29 2007-04-01 Institut National De La Sante Et De La Recherche Medicale (Inserm) NEW HUMAN ULIP / CRMP PROTEIN AND ITS USE IN THE DIAGNOSIS AND THERAPY OF CANCERES AND PARANEOPLASIC NEUROLOGICAL SYNDROMES.
CA2429196A1 (en) 2000-03-24 2001-10-04 Duke University Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
US7235649B2 (en) 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
WO2001090321A2 (en) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 55158, a novel human carbonic anhydrase and uses thereof
JPWO2003008446A1 (en) * 2001-07-19 2004-11-11 三菱ウェルファーマ株式会社 Polypeptides involved in late glycation end product receptor signaling
WO2003027279A1 (en) * 2001-09-25 2003-04-03 Sony Corporation p300 HISTONE ACETYLASE INHIBITOR
WO2003044171A2 (en) * 2001-11-16 2003-05-30 Incyte Genomics, Inc. Organelle-associated proteins
WO2003045990A2 (en) * 2001-11-26 2003-06-05 Hybrigenics Protein-protein interactions involving transforming growth factor beta signalling
ATE364096T1 (en) * 2002-03-20 2007-06-15 Novartis Pharma Gmbh METHOD FOR THE DIAGNOSIS AND THERAPY OF SCHIZOPHRENIA
GB0217033D0 (en) * 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
KR101083852B1 (en) * 2002-07-25 2011-11-15 소니 주식회사 A gene transcription regulator and a screening method for a compound inhibiting histone deacetylase
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2004090113A2 (en) * 2003-03-31 2004-10-21 Seattle Genetics, Inc. L53, a lung cancer associated antigen and uses thereof
JPWO2005097204A1 (en) * 2004-04-09 2008-02-28 武田薬品工業株式会社 Cancer preventive / therapeutic agent
EP1846041A4 (en) * 2004-10-29 2008-05-07 Univ Rochester Modified bacteriophage vectors and uses thereof
EP1909815A4 (en) * 2005-07-26 2011-05-18 Cms Peptides Patent Holding Company Ltd Novel biologically active peptides and their new uses
US20160017011A1 (en) * 2013-02-26 2016-01-21 Rongfu Wang Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy
US11795201B2 (en) 2017-04-14 2023-10-24 University Of Massachusetts Brown fat-selective adipokines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
EP1130094A3 (en) * 1999-07-08 2001-11-21 Helix Research Institute Primers for synthesizing full length cDNA clones and their use
US20040034192A1 (en) * 2000-01-06 2004-02-19 Seishi Kato Human proteins having hyprophobic domains and dnas encoding these proteins

Also Published As

Publication number Publication date
EP1276751A4 (en) 2005-04-06
AU2001241511A1 (en) 2001-09-12
CA2401505A1 (en) 2001-09-07
EP1276751A2 (en) 2003-01-22
WO2001064834A2 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
WO2001064835A8 (en) Novel nucleic acids and polypeptides
WO2001064834A8 (en) Novel nucleic acids and polypeptides
CY1118443T1 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
ATE469911T1 (en) ISOLATED NUCLEIC ACID MOLECULES ENCODING T-CELL INDUCIBLE FACTORS (TIF), ENCODED PROTEINS AND THEIR APPLICATIONS
NO20020348L (en) Peptide acceptor ligation methods
DK1015586T3 (en) TIE receptortyrosinkinaseligandhomologer
MXPA02004666A (en) Recombinant gelatins.
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
ATE541857T1 (en) OPTIMIZED FC VARIANTS AND MANUFACTURING PROCESSES THEREOF
ATE317441T1 (en) CATHEPSIN-02 PROTEASE
ATE411082T1 (en) NEW USE OF SHORT CHAIN CARBOXYLIC ACIDS
WO2001088088A3 (en) Novel nucleic acids and polypeptides
CY1109207T1 (en) ECHINOCANDINI PROCEDURE
BR0100991B1 (en) fuel pumping assembly.
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
SE9801455D0 (en) New receptor
DK1157100T3 (en) Oxaloacetate hydrolase-defective fungal host cells
TR200501541T2 (en) Signal sequences of the dissociation of Leu-hirudin with e.coli in culture medium
ATE439441T1 (en) MODIFIED FLUORESCENT PROTEINS
ATE321853T1 (en) HUMANIC PELLINO-POLYPEPTIDES
WO2001079449A3 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

D17 Declaration under article 17(2)a
WWE Wipo information: entry into national phase

Ref document number: 2401505

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001912764

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001912764

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10220335

Country of ref document: US

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001912764

Country of ref document: EP